You are here: Home Published Research Safety and reactogenicity of primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Vietnamese infants: a randomised, controlled trial.

Tran N Huu, Nguyen T Toan, Ha M Tuan, Ho L Viet, Pham Le Thanh Binh, Ta-Wen Yu, Fakrudeen Shafi, Ahsan Habib, and Dorota Borys (2013)

Safety and reactogenicity of primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Vietnamese infants: a randomised, controlled trial.

BMC infectious diseases, 13(1):95.

Pneumococcal infections are major causes of child mortality and morbidity worldwide and antibiotic resistance of Streptococcus pneumoniae is a major concern, especially in Asian countries. The present study was designed to evaluate the reactogenicity and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the licensed diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliovirus and H. influenzae type b vaccine (DTPa-HBV-IPV/Hib) in a 3-dose primary vaccination course in Vietnamese infants.

Bacterial Proteins, Carrier Proteins, Diphtheria-Tetanus-Pertussis Vaccine, Drug-Related Side Effects and Adverse Reactions, Female, Hepatitis B Vaccines, Humans, Immunoglobulin D, Infant, Infant, Newborn, Lipoproteins, Male, Pneumococcal Vaccines, Poliovirus Vaccine, Inactivated, Vaccines, Combined, Vaccines, Conjugate, Vietnam
Bacterial Proteins, Carrier Proteins, Diphtheria-Tetanus-Pertussis Vaccine, Drug-Related Side Effects and Adverse Reactions, Female, Hepatitis B Vaccines, Humans, Immunoglobulin D, Infant, Infant, Newborn, Lipoproteins, Male, Pneumococcal Vaccines, Poliovirus Vaccine, Inactivated, Vaccines, Combined, Vaccines, Conjugate, Vietnam
 
Document Actions